You can buy or sell Intrexon and other stocks, options, ETFs, and crypto commission-free!
Intrexon Corporation Common Stock, also called Intrexon, is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. Read More The product pipeline includes Isobutanol, Isobutyraldehyde, Farnesene, and Isoprene. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.
52 Week High
52 Week Low
Yahoo FinanceMay 21
Weekly CEO Buys Highlight
- By Joy Hu According to GuruFocus Insider Data, these are the largest CEO buys during the past week. Intrexon CEO bought 2,096,209 shares Scroll to continue with content Ad Intrexon Corp. (XON) CEO and 10% Owner Randal J. Kirk bought 2,096,209 shares during the past week at the average price of $4.40. Intrexon is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of...
Cramer's lighting round: I feel bad if you own Intrexon — It's a loser
Intrexon Corp.: "This is a loser and I don't want to hear about it. I feel bad if you own it, but it's a loser. Iridium Communications Inc.: "[CEO] Matt Desch. I thought he did a great job. I like the stock. It's got a niche business that I didn't believe in. I was wrong, he was right. It's a winner." Wayfair Inc.: "This is a rough market right now and Wayfair is the kind of stock that's not necessarily the best thing to buy at this moment. I do think the company has tremendous growth." Zscaler Inc.: "I ...
Yahoo FinanceMay 13
Intrexon to Present at the Bank of America Merrill Lynch 2019 Healthcare Conference
GERMANTOWN, Md., May 13, 2019 /PRNewswire/ -- Intrexon Corporation (XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced Randal J. Kirk, Chairman and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2019 Healthcare Conference in Las Vegas on Wednesday, May 15th, at 3:40 p.m. Pacific Time.
Expected Aug 9, After Hours